Arielle S Selya1, Naa Dede Hesse2. 1. Master of Public Health Program, Department of Population Health, University of North Dakota, United States. Electronic address: arielle.selya@med.und.edu. 2. Master of Public Health Program, Department of Population Health, University of North Dakota, United States.
Abstract
RATIONALE: Cigarette smoking is a primary cause of cardiovascular disease (CVD); however, prior research has rarely distinguished smoking behavior from nicotine dependence. OBJECTIVE: The current study presents a novel investigation into whether time to first cigarette (TTFC), a reliable proxy for nicotine dependence, is associated with lipid cholesterol, a biomarker for CVD, after controlling for smoking behavior and other risk factors. METHODS: In total, 3903 current adult smokers were drawn from four consecutive cross-sectional waves (2005-06, 2007-08, 2009-10, and 2011-12) of the National Health and Nutrition Survey (NHANES). Weighted regressions were used to examine whether earlier TTFC is associated with differences in a) numeric values; b) guideline-based binary outcomes of total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and the LDL/HDL ratio; and c) 10-year risk scores for CVD. RESULTS: Earlier TTFC (within 5, 30, or 60 min vs. >60 min) was significantly (p < 0.05) associated with lower HDL (2-3 mg/dL) and a lower odds ratio (OR = 0.70) of having optimal HDL levels, and a lower LDL/HDL ratio (0.14-0.32); these results were consistent across three models (unadjusted, adjusted for smoking behavior, and also adjusted for demographics and other CVD risk factors). Earlier TTFC was also associated (p < 0.05) with higher odds of having sub-optimal total cholesterol levels (OR = 1.55) and higher LDL values (8 mg/dL), but only in the models adjusting for smoking behavior. However, the association of TTFC with 10-year CVD risk scores did not reach significance (p > 0.05). CONCLUSION: More "addicted" smokers, as indicated by earlier TTFC, have less favorable lipid profiles, even after accounting for current and lifetime smoking history and other CVD risk factors. Future research should further explore whether TTFC could be a useful tool for refining clinically significant CVD risk among smokers.
RATIONALE: Cigarette smoking is a primary cause of cardiovascular disease (CVD); however, prior research has rarely distinguished smoking behavior from nicotine dependence. OBJECTIVE: The current study presents a novel investigation into whether time to first cigarette (TTFC), a reliable proxy for nicotine dependence, is associated with lipidcholesterol, a biomarker for CVD, after controlling for smoking behavior and other risk factors. METHODS: In total, 3903 current adult smokers were drawn from four consecutive cross-sectional waves (2005-06, 2007-08, 2009-10, and 2011-12) of the National Health and Nutrition Survey (NHANES). Weighted regressions were used to examine whether earlier TTFC is associated with differences in a) numeric values; b) guideline-based binary outcomes of total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and the LDL/HDL ratio; and c) 10-year risk scores for CVD. RESULTS: Earlier TTFC (within 5, 30, or 60 min vs. >60 min) was significantly (p < 0.05) associated with lower HDL (2-3 mg/dL) and a lower odds ratio (OR = 0.70) of having optimal HDL levels, and a lower LDL/HDL ratio (0.14-0.32); these results were consistent across three models (unadjusted, adjusted for smoking behavior, and also adjusted for demographics and other CVD risk factors). Earlier TTFC was also associated (p < 0.05) with higher odds of having sub-optimal total cholesterol levels (OR = 1.55) and higher LDL values (8 mg/dL), but only in the models adjusting for smoking behavior. However, the association of TTFC with 10-year CVD risk scores did not reach significance (p > 0.05). CONCLUSION: More "addicted" smokers, as indicated by earlier TTFC, have less favorable lipid profiles, even after accounting for current and lifetime smoking history and other CVD risk factors. Future research should further explore whether TTFC could be a useful tool for refining clinically significant CVD risk among smokers.
Authors: David T Ip; Joanna E Cohen; Susan J Bondy; Michael O Chaiton; Peter Selby; Robert Schwartz; Paul McDonald; John Garcia; Roberta Ferrence Journal: Addiction Date: 2012-02 Impact factor: 6.526
Authors: Ursula Kunze; Eva Schöler; Rudolf Schoberberger; Christian Dittrich; Kurt Aigner; Pal Bölcskei; Ernest Groman Journal: Nicotine Tob Res Date: 2007-05 Impact factor: 4.244
Authors: David C Goff; Donald M Lloyd-Jones; Glen Bennett; Sean Coady; Ralph B D'Agostino; Raymond Gibbons; Philip Greenland; Daniel T Lackland; Daniel Levy; Christopher J O'Donnell; Jennifer G Robinson; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Paul Sorlie; Neil J Stone; Peter W F Wilson; Harmon S Jordan; Lev Nevo; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli Journal: Circulation Date: 2013-11-12 Impact factor: 29.690
Authors: Lisa Dierker; Donald Hedeker; Jennifer Rose; Arielle Selya; Robin Mermelstein Journal: Drug Alcohol Depend Date: 2015-03-19 Impact factor: 4.492
Authors: Dana B Hancock; Jen-Chyong Wang; Nathan C Gaddis; Joshua L Levy; Nancy L Saccone; Jerry A Stitzel; Alison Goate; Laura J Bierut; Eric O Johnson Journal: Hum Mol Genet Date: 2015-07-28 Impact factor: 6.150
Authors: Timothy B Baker; Megan E Piper; Danielle E McCarthy; Daniel M Bolt; Stevens S Smith; Su-Young Kim; Suzanne Colby; David Conti; Gary A Giovino; Dorothy Hatsukami; Andrew Hyland; Suchitra Krishnan-Sarin; Raymond Niaura; Kenneth A Perkins; Benjamin A Toll Journal: Nicotine Tob Res Date: 2007-11 Impact factor: 4.244
Authors: Fangyi Gu; Sholom Wacholder; Stephanie Kovalchik; Orestis A Panagiotou; Carolyn Reyes-Guzman; Neal D Freedman; Sara De Matteis; Dario Consonni; Pier Alberto Bertazzi; Andrew W Bergen; Maria Teresa Landi; Neil E Caporaso Journal: J Natl Cancer Inst Date: 2014-06-19 Impact factor: 13.506